Submitted by Anonymous (not verified) on 12 July 2024 - 15:15
Human medicines European public assessment report (EPAR): Kesimpta, ofatumumab, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kesimpta, ofatumumab, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised